Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CymaBay Therapeutics (CBAY)

  • Company Report
  • March 23, 2023, 23:15 UTC
  • 37

New SEC Form for CymaBay Therapeutics

Comment Full text

ADMA Biologics Inc (ADMA)

  • Company Report
  • March 23, 2023, 23:10 UTC
  • 46

ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Company Report
  • March 23, 2023, 15:34 UTC
  • 43

Moleculin Biotech, Inc. SEC filing

Comment Full text

Monopar Therapeutics Inc. (MNPR)

  • Company Report
  • March 23, 2023, 14:14 UTC
  • 42

New SEC Form for Monopar Therapeutics Inc.

Comment Full text

Kiora Pharmaceuticals Inc. (KPRX)

  • Company Report
  • March 23, 2023, 14:10 UTC
  • 39

New SEC Form for Kiora Pharmaceuticals, Inc.

Comment Full text

Innate Pharma S.A. (IPHA)

  • Company Report
  • March 23, 2023, 09:05 UTC
  • 47

Innate Pharma - Fourth Quarter 2022

Comment Full text

Orgenesis Inc. (ORGS)

  • Company Report
  • March 23, 2023, 00:30 UTC
  • 40

New SEC Form

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Company Report
  • March 22, 2023, 23:40 UTC
  • 40

Moleculin Biotech, Inc. SEC filing

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Company Report
  • March 22, 2023, 23:40 UTC
  • 41

Moleculin Biotech, Inc. SEC filing

Comment Full text

Sera Prognostics Inc (SERA)

  • Company Report
  • March 22, 2023, 23:35 UTC
  • 37

New SEC Filing for Sera Prognostics Inc. (NASDAQ:SERA)

Comment Full text
  • Previous
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next

Search

News categories

  • Technical Exchange News(9087)
  • Event(407)
  • SEC News(144099)
  • FDA Approval(8437)
  • Company Report(721)
  • Business News(100744)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin